{"id":"https://openalex.org/W7225745562","doi":"https://doi.org/10.6084/m9.figshare.34967012","title":"Reimagining COPD treatment: are biologics the next frontier?","display_name":"Reimagining COPD treatment: are biologics the next frontier?","publication_year":2026,"publication_date":"2026-11-10","ids":{"openalex":"https://openalex.org/W7225745562","doi":"https://doi.org/10.6084/m9.figshare.34967012"},"language":"en","primary_location":{"id":"doi:10.6084/m9.figshare.34967012","doi":"https://doi.org/10.6084/m9.figshare.34967012","is_oa":true,"landing_page_url":"https://doi.org/10.6084/m9.figshare.34967012","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["datacite"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://doi.org/10.6084/m9.figshare.34967012","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5053217610","display_name":"Paola Rogliani","orcid":"https://orcid.org/0000-0001-7801-5040","observed_orcids":["https://orcid.org/0000-0001-7801-5040"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Paola Rogliani","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161383164","display_name":"Ilaria De Guido","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ilaria De Guido","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083960140","display_name":"Shima Gholamalishahi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shima Gholamalishahi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111575475","display_name":"Mario Cazzola","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mario Cazzola","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5035810516","display_name":"Luigino Calzetta","orcid":"https://orcid.org/0000-0003-0456-069X","observed_orcids":["https://orcid.org/0000-0003-0456-069X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Luigino Calzetta","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10143","display_name":"Chronic Obstructive Pulmonary Disease (COPD) Research","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10143","display_name":"Chronic Obstructive Pulmonary Disease (COPD) Research","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10051","display_name":"Asthma and respiratory diseases","score":0.00139999995008111,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11651","display_name":"Inhalation and Respiratory Drug Delivery","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8720999956130981},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.7164000272750854},{"id":"https://openalex.org/C2781293274","wikidata":"https://www.wikidata.org/wiki/Q5376560","display_name":"Endotype","level":3,"score":0.6367999911308289},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.6277999877929688},{"id":"https://openalex.org/C3020000205","wikidata":"https://www.wikidata.org/wiki/Q2412849","display_name":"Narrative review","level":2,"score":0.6022999882698059},{"id":"https://openalex.org/C2776780178","wikidata":"https://www.wikidata.org/wiki/Q199804","display_name":"COPD","level":2,"score":0.5591999888420105},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.5253999829292297},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.4814999997615814},{"id":"https://openalex.org/C163763905","wikidata":"https://www.wikidata.org/wiki/Q17075943","display_name":"Precision medicine","level":2,"score":0.3668000102043152},{"id":"https://openalex.org/C2992779976","wikidata":"https://www.wikidata.org/wiki/Q3286546","display_name":"Pulmonary disease","level":2,"score":0.36090001463890076},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.3479999899864197},{"id":"https://openalex.org/C2780664029","wikidata":"https://www.wikidata.org/wiki/Q5282120","display_name":"Disease burden","level":3,"score":0.34380000829696655},{"id":"https://openalex.org/C3020448403","wikidata":"https://www.wikidata.org/wiki/Q5282120","display_name":"Burden of disease","level":3,"score":0.33660000562667847},{"id":"https://openalex.org/C2777832160","wikidata":"https://www.wikidata.org/wiki/Q3306175","display_name":"Mepolizumab","level":4,"score":0.3292999863624573},{"id":"https://openalex.org/C189708586","wikidata":"https://www.wikidata.org/wiki/Q1504425","display_name":"Systematic review","level":3,"score":0.32409998774528503},{"id":"https://openalex.org/C2911221801","wikidata":"https://www.wikidata.org/wiki/Q2742406","display_name":"Biologic Agents","level":3,"score":0.30059999227523804},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2992999851703644},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.2976999878883362},{"id":"https://openalex.org/C2781230642","wikidata":"https://www.wikidata.org/wiki/Q492646","display_name":"Targeted therapy","level":3,"score":0.2768000066280365},{"id":"https://openalex.org/C32220436","wikidata":"https://www.wikidata.org/wiki/Q2072214","display_name":"Personalized medicine","level":2,"score":0.2605000138282776},{"id":"https://openalex.org/C163864487","wikidata":"https://www.wikidata.org/wiki/Q6901461","display_name":"Monoclonal","level":4,"score":0.25049999356269836}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.6084/m9.figshare.34967012","doi":"https://doi.org/10.6084/m9.figshare.34967012","is_oa":true,"landing_page_url":"https://doi.org/10.6084/m9.figshare.34967012","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},{"id":"doi:10.6084/m9.figshare.34967012.v1","doi":"https://doi.org/10.6084/m9.figshare.34967012.v1","is_oa":true,"landing_page_url":"https://doi.org/10.6084/m9.figshare.34967012.v1","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"}],"best_oa_location":{"id":"doi:10.6084/m9.figshare.34967012","doi":"https://doi.org/10.6084/m9.figshare.34967012","is_oa":true,"landing_page_url":"https://doi.org/10.6084/m9.figshare.34967012","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":[],"abstract_inverted_index":{"Chronic":[0],"obstructive":[1],"pulmonary":[2],"disease":[3,27],"(COPD)":[4],"remains":[5],"a":[6,31],"leading":[7],"cause":[8],"of":[9,26,44,84,95,108],"morbidity":[10],"and":[11,17,59,86,120,132,138,175,184],"mortality":[12],"with":[13,100,126],"persistent":[14],"symptom":[15],"burden":[16],"frequent":[18],"exacerbations":[19],"despite":[20],"optimized":[21],"inhaled":[22],"therapy.":[23],"Growing":[24],"recognition":[25],"heterogeneity":[28],"such":[29],"as":[30,35,37,48],"distinct":[32],"type-2/eosinophilic":[33],"endotype":[34,171],"well":[36],"advances":[38],"in":[39,64,147,163],"biologic":[40,96],"agents":[41,67],"motivate":[42],"reassessment":[43],"monoclonal":[45],"antibodies":[46],"(mAbs)":[47],"targeted":[49],"treatments.":[50],"This":[51],"narrative":[52],"review":[53],"summarizes":[54],"evidence":[55],"from":[56],"Phase":[57],"2":[58],"3":[60],"studies":[61,94],"for":[62,98,178],"mAbs":[63],"COPD,":[65,99],"grouping":[66],"by":[68],"molecular":[69],"targets":[70],"(IL-1\u03b2,":[71],"IL-4/IL-4":[72],"R\u03b1/IL-13,":[73],"IL-5/IL-5":[74],"R\u03b1,":[75],"IL-8,":[76],"IL-17,":[77],"IL-33/ST2/RAGE/EGFR,":[78],"TSLP,":[79],"TNF-\u03b1).":[80],"A":[81],"literature":[82],"search":[83,102],"MEDLINE":[85],"ClinicalTrials.gov":[87],"was":[88],"conducted":[89],"to":[90],"identify":[91],"relevant":[92],"clinical":[93,192],"therapies":[97,123],"the":[101],"updated":[103],"through":[104],"November":[105],"2025.":[106],"Trials":[107],"canakinumab,":[109],"dupilumab,":[110],"mepolizumab,":[111],"benralizumab,":[112],"ABX-IL8,":[113],"CNTO":[114],"6785,":[115],"astegolimab,":[116],"itepekimab,":[117],"tozorakimab,":[118],"tezepelumab,":[119],"earlier":[121],"neutrophil-directed":[122],"are":[124,187],"reviewed,":[125],"emphasis":[127],"on":[128,169],"biomarker-guided":[129],"enrichment,":[130],"primary":[131],"key":[133],"secondary":[134],"outcomes,":[135],"subgroup":[136],"signals,":[137],"safety":[139],"profiles.":[140],"Broad":[141],"anti-inflammatory":[142],"approaches":[143],"have":[144],"largely":[145],"failed":[146],"unselected":[148],"COPD":[149],"populations.":[150],"By":[151],"contrast,":[152],"biologics":[153],"targeting":[154],"type-2":[155],"inflammation":[156],"or":[157],"upstream":[158],"epithelial":[159],"alarmins":[160],"show":[161],"benefit":[162],"biomarker-defined":[164],"subgroups.":[165],"Future":[166],"success":[167],"depends":[168],"precise":[170],"definition,":[172],"validated":[173],"biomarkers,":[174],"trials":[176],"designed":[177],"enriched":[179],"populations;":[180],"careful":[181],"risk\u2013benefit":[182],"assessment":[183],"real-world":[185],"validation":[186],"essential":[188],"before":[189],"designing":[190],"future":[191],"trials.":[193]},"counts_by_year":[],"updated_date":"2026-11-11T12:16:26.678958","created_date":"2026-11-11T00:00:00"}